These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6205948)

  • 1. [Clinical studies for the subclassification of chronic myelogenous leukemia (CML) into chronic granulocytic and chronic megakaryocytic- granulocytic leukemia (CGL/CMGL)].
    Helbig W; Kubel M; Schwenke H; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):266-70. PubMed ID: 6205948
    [No Abstract]   [Full Text] [Related]  

  • 2. The value of bone marrow biopsy in chronic myeloid leukaemia.
    Seewann HL; Lehnert M; Jüttner F
    Haematologia (Budap); 1983; 16(1-4):67-72. PubMed ID: 6592124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative clinical and histological investigations in chronic myeloid leukaemias ].
    Seewann HL; Jüttner F; Vykoupil KF
    Wien Klin Wochenschr; 1982 May; 94(10):270-2. PubMed ID: 6957071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations of chronic granulocytic leukemia.
    Spiers AS
    Semin Oncol; 1995 Aug; 22(4):380-95. PubMed ID: 7638635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic megakaryocytic granulocytic myelosis-CMGM. A subtype of chronic myeloid leukemia.
    Georgii A; Vykoupil KF; Thiele J
    Virchows Arch A Pathol Anat Histol; 1980; 389(3):253-68. PubMed ID: 6935864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of histologic bone marrow evaluation in diagnosis of chronic granulocytic leukemia. II. Megakaryocytes].
    Komarnicki M; Rasińska M; Woźny T
    Acta Haematol Pol; 1995; 26(2):195-200. PubMed ID: 7653225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of blastic transformation of chronic granulocytic leukemia by high dose cyclophosphamide, total body irradiation and infusion of cryopreserved autologous marrow.
    Buckner CD; Clift RA; Fefer A; Neiman PE; Storb R; Thomas ED
    Exp Hematol; 1974; 2(3):138-46. PubMed ID: 4616842
    [No Abstract]   [Full Text] [Related]  

  • 8. Infantile type of chronic myelogenous leukemia in a 16-year-old boy.
    Bennett AJ; Jason M; Grünwald HW; Rosner F
    Am J Pediatr Hematol Oncol; 1979; 1(4):369-74. PubMed ID: 296655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Six cases with megakaryocytic transformation of chronic myelogenous leukemia].
    Ono Y; Ino T; Takada T; Okamoto M; Morikawa K; Imura H; Takeda N; Shirakawa S; Ezaki K; Hirano M
    Rinsho Ketsueki; 1986 Mar; 27(3):360-8. PubMed ID: 3461182
    [No Abstract]   [Full Text] [Related]  

  • 10. Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia.
    Michiels JJ; Berneman Z; Schroyens W; Kutti J; Swolin B; Ridell B; Fernando P; Zanetto U
    Ann Hematol; 2004 Aug; 83(8):504-12. PubMed ID: 15164229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
    Thiele J; Funke S; Holgado S; Choritz H; Georgii A
    Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts in chronic myelogenous leukemia.
    Stryckmans PA
    Semin Hematol; 1974 Apr; 11(2):101-27. PubMed ID: 4595812
    [No Abstract]   [Full Text] [Related]  

  • 14. [The megakaryoblastic phase of chronic granulocytic leukemia].
    Kiss A; Oláh E; Iványi JL; Pecze K; Telek B; Pfliegler G; Rák K
    Orv Hetil; 1986 Apr; 127(15):871-7. PubMed ID: 3458156
    [No Abstract]   [Full Text] [Related]  

  • 15. [Megakaryoblastic transformation in chronic myelogenous leukemia].
    Kiss A; Iványi JL; Nagy P; Mikita J; Oláh E; Rak K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):276-82. PubMed ID: 6205950
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological classification of chronic granulocytic leukaemia.
    Knox WF; Bhavnani M; Davson J; Geary CG
    Clin Lab Haematol; 1984; 6(2):171-5. PubMed ID: 6593144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluripotent, erythrocytic and granulocytic hemopoietic precursors in chronic granulocytic leukemia.
    Hara H; Kai S; Fushimi M; Taniwaki S; Ifuku H; Okamoto T; Ohe Y; Fujita S; Noguchi K; Kanamaru A; Nagai K; Inada E
    Exp Hematol; 1981 Sep; 9(8):871-7. PubMed ID: 6948685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2 cases of chronic myelogenous leukemia with megakaryocytic transformation].
    Ino T; Saito M; Shigemura H; Morishita Y; Hirano M; Shamoto M
    Rinsho Ketsueki; 1982 Apr; 23(4):484-92. PubMed ID: 6957630
    [No Abstract]   [Full Text] [Related]  

  • 20. Econometric analysis of phase duration for blood morphology and basophil count alterations in chronic granulocytic leukaemia.
    Gola A; Smakowska E; Waszkiewicz L; Błaczkowska A; Kin-Dittmann I; Zielińska K; Czajkowska B; Pajsert E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):271-5. PubMed ID: 6205949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.